These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32131556)

  • 1. Immune Phenotype and Functionality of
    Mupfumi L; Mpande CAM; Reid T; Moyo S; Shin SS; Zetola N; Mogashoa T; Musonda RM; Kasvosve I; Scriba TJ; Nemes E; Gaseitsiwe S
    Pathogens; 2020 Mar; 9(3):. PubMed ID: 32131556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment.
    Díaz-Fernández S; Villar-Hernández R; Stojanovic Z; Fernández M; Galvão MLS; Tolosa G; Sánchez-Montalva A; Abad J; Jiménez-Fuentes MÁ; Safont G; Romero I; Sabrià J; Prat C; Domínguez J; Latorre I
    Front Microbiol; 2022; 13():885312. PubMed ID: 35935194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
    Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C
    Front Immunol; 2018; 9():2247. PubMed ID: 30323818
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease extent and anti-tubercular treatment response correlates with
    Riou C; Du Bruyn E; Ruzive S; Goliath RT; Lindestam Arlehamn CS; Sette A; Sher A; Barber DL; Wilkinson RJ
    Clin Transl Immunology; 2020; 9(9):e1176. PubMed ID: 33005414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Phenotype of
    Riou C; Berkowitz N; Goliath R; Burgers WA; Wilkinson RJ
    Front Immunol; 2017; 8():968. PubMed ID: 28848561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment.
    Chiacchio T; Petruccioli E; Pepponi I; Vanini V; Gualano G; Cirillo D; Palmieri F; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S141-S142. PubMed ID: 28043513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients.
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; Pinnetti C; Sampaolesi A; Antinori A; Girardi E; Goletti D
    J Infect; 2014 Dec; 69(6):533-45. PubMed ID: 24975174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis.
    Petruccioli E; Petrone L; Vanini V; Cuzzi G; Navarra A; Gualano G; Palmieri F; Girardi E; Goletti D
    J Infect; 2015 Nov; 71(5):526-33. PubMed ID: 26253021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27
    Fang Y; Tang Y; Luo QX; Wang N; Tang L; Yang XJ; You XF; Wang YC; Liang L; Zhang JB; Su B; Sha W
    Eur J Med Res; 2024 Mar; 29(1):147. PubMed ID: 38429734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of
    Sitoe N; Ahmed MIM; Enosse M; Bakuli A; Chissumba RM; Held K; Hoelscher M; Nhassengo P; Khosa C; Rachow A; Geldmacher C; On Behalf Of Tb Sequel Consortium
    Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD38+CD27-TNF-α + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis.
    Acharya MP; Pradeep SP; Murthy VS; Chikkannaiah P; Kambar V; Narayanashetty S; Burugina Nagaraja S; Gangadhar N; Yoganand R; Satchidanandam V
    Clin Infect Dis; 2021 Sep; 73(5):793-801. PubMed ID: 34492697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-TB coinfection impairs CD8(+) T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses.
    Suarez GV; Angerami MT; Vecchione MB; Laufer N; Turk G; Ruiz MJ; Mesch V; Fabre B; Maidana P; Ameri D; Cahn P; Sued O; Salomón H; Bottasso OA; Quiroga MF
    Eur J Immunol; 2015 Sep; 45(9):2529-41. PubMed ID: 26047476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent TB and HIV therapies effectively control clinical reactivation of TB during co-infection but fail to eliminate chronic immune activation.
    Sharan R; Zou Y; Lai Z; Singh B; Shivanna V; Dick E; Hall-Ursone S; Khader S; Mehra S; Alvarez X; Rengarajan J; Kaushal D
    Res Sq; 2024 Aug; ():. PubMed ID: 39257997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients.
    Wang F; Mao L; Hou H; Wu S; Huang M; Yin B; Huang J; Zhu Q; Pan Y; Sun Z
    Int Immunopharmacol; 2016 Mar; 32():39-45. PubMed ID: 26796515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.